Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Teleflex Incorporated (NYSE:TFX - Get Rating) was the recipient of a large decrease in short interest in August. As of August 15th, there was short interest totalling 1,180,000 shares, a decrease of 25.3% from the July 31st total of 1,580,000 shares. Based on an average daily volume of 396,800 shares, the short-interest ratio is presently 3.0 days. Insiders Place Their Bets

In other news, Director Stuart A. Randle sold 3,014 shares of Teleflex stock in a transaction that occurred on Tuesday, June 7th. The shares were sold at an average price of $283.31, for a total value of $853,896.34. Following the completion of the sale, the director now directly owns 4,320 shares in the company, valued at $1,223,899.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 1.28% of the company's stock. Institutional Trading of Teleflex

Several hedge funds have recently bought and sold shares of the business. Investors Asset Management of Georgia Inc. GA ADV bought a new position in shares of Teleflex in the second quarter valued at $25,000. Clear Street Markets LLC lifted its position in Teleflex by 426.3% in the 2nd quarter. Clear Street Markets LLC now owns 100 shares of the medical technology company's stock valued at $25,000 after acquiring an additional 81 shares in the last quarter. Massmutual Trust Co. FSB ADV lifted its position in Teleflex by 141.9% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 104 shares of the medical technology company's stock valued at $26,000 after acquiring an additional 61 shares in the last quarter. City State Bank acquired a new position in Teleflex during the 4th quarter valued at about $27,000. Finally, Hallmark Capital Management Inc. bought a new stake in Teleflex during the 2nd quarter worth approximately $31,000. Institutional investors and hedge funds own 92.21% of the company's stock. Wall Street Analysts Forecast Growth

A number of brokerages recently commented on TFX. Truist Financial decreased their price target on Teleflex to $270.00 in a research report on Friday, July 22nd. Bank of America started coverage on Teleflex in a report on Monday, May 9th. They issued a "neutral" rating and a $315.00 target price on the stock. Royal Bank of Canada decreased their target price on shares of Teleflex from $390.00 to $380.00 in a research report on Monday, May 23rd. Piper Sandler dropped their price target on shares of Teleflex from $295.00 to $265.00 in a research report on Thursday, July 28th. Finally, TheStreet lowered shares of Teleflex from a "b-" rating to a "c+" rating in a research note on Monday, May 16th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $340.09.Teleflex Trading Down 4.5 %

NYSE:TFX opened at $224.14 on Friday. Teleflex has a 12 month low of $223.07 and a 12 month high of $405.89. The company has a current ratio of 2.27, a quick ratio of 1.43 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $10.51 billion, a price-to-earnings ratio of 20.83, a PEG ratio of 2.26 and a beta of 1.10. The firm has a fifty day simple moving average of $249.88 and a two-hundred day simple moving average of $291.04.

Teleflex (NYSE:TFX - Get Rating) last released its quarterly earnings data on Thursday, July 28th. The medical technology company reported $3.39 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.34 by $0.05. Teleflex had a net margin of 18.16% and a return on equity of 16.84%. The company had revenue of $704.50 million for the quarter, compared to analysts' expectations of $719.50 million. During the same quarter in the prior year, the firm earned $3.35 EPS. The business's revenue was down 1.3% on a year-over-year basis. Analysts expect that Teleflex will post 13.16 EPS for the current fiscal year. Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 15th. Investors of record on Monday, August 15th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date is Friday, August 12th. Teleflex's dividend payout ratio is currently 12.64%. About Teleflex (Get Rating)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.Read MoreGet a free copy of the StockNews.com research report on Teleflex (TFX)Why This Dip in Advanced Auto Parts May be an OpportunityMarketBeat: Week in Review 8/22 - 8/26Institutional Buying Put A Bottom In Marvell Technology Dell Stock Retreats On Weaker Sales, Falls Into Value Terrirtory3 Reasons Dollar General’s Rally Has Legs

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Tom remains optimistic about investors’ prospects going forward, even as the market reacts to the words of Fed Chair Jerome Powell about “pain ahead.”

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.